Seven facts and five initiatives for gut microbiome research

References

1 Aagaard K, Hohmann E (2019) Regulating microbiome manipulation. Nat Med 25(6):874–876

2 Ascherio A, Schwarzschild MA (2016) The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol 15 (12):1257–1272

3 Avetisyan M, Schill EM, Heuckeroth RO (2015) Building a second brain in the bowel. J Clin Invest 125(3):899–907

4 Bai D, Yip BHK, Windham GC, Sourander A, Francis R, Yoffe R, Glasson E, Mahjani B, Suominen A, Leonard H (2019) Association of genetic and environmental factors with autism in a 5-country cohort. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2019.1411

5 Barnard ND, Willett WC, Ding EL (2017) The misuse of metaanalysis in nutrition research. JAMA 318(15):1435–1436

6 Belkaid Y, Harrison OJ (2017) Homeostatic immunity and the microbiota. Immunity 46(4):562–576

7 Bothwell LE, Podolsky SH (2016) The emergence of the randomized, controlled trial. N Engl J Med 375(6):501–504

8 Bunyavanich S (2019) Food allergy: could the gut microbiota hold the key? Nat Rev Gastroenterol Hepatol 16(4):201–202

9 Byndloss MX, Bäumler AJ (2018) The germ-organ theory of noncommunicable diseases. Nat Rev Microbiol 16(2):103–110

10 Canfora EE, Meex RCR, Venema K, Blaak EE (2019) Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol 15 (5):261–273

11 Chatterjee S, Khunti K, Davies MJ (2017) Type 2 diabetes. Lancet Lond Engl 389(10085):2239–2251

12 Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148 (6):1258–1270

13 Clemente JC, Manasson J, Scher JU (2018) The role of the gut microbiome in systemic inflammatory disease. BMJ 360:j5145

14 Cohen PA (2018) Probiotic safety-no guarantees. JAMA Intern Med 178(12):1577–1578

15 Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F, Tramontano M, Driessen M, Hercog R, Jung F-E (2017) Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol 35(11):1069–1076

16 Crow D (2018) Microbiome research in a social world. Cell 172 (6):1143–1145

17 Cryan JF, O’Riordan KJ, Sandhu K, Peterson V, Dinan TG (2020) The gut microbiome in neurological disorders. Lancet Neurol 19 (2):179–194

18 Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol 16(8):461–478

19 Dauby N (2017) Risks of Saccharomyces boulardii-containing probiotics for the prevention of clostridium difficile infection in the elderly. Gastroenterology 153(5):1450–1451

20 DeFilipp Z, Bloom PP, Torres Soto M, Mansour MK, Sater MRA, Huntley MH, Turbett S, Chung RT, Chen Y-B, Hohmann EL (2019) Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med 381(21):2043–2050

21 Djulbegovic B, Guyatt GH (2017) Progress in evidence-based medicine: a quarter century on. Lancet Lond Engl 390 (10092):415–423

22 Dominguez-Bello MG, Peterson D, Noya-Alarcon O, Bevilacqua M, Rojas N, Rodríguez R, Pinto SA, Baallow R, Caballero-Arias H (2016) Ethics of exploring the microbiome of native peoples. Nat Microbiol 1(7):16097

23 Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, White RC, Clarke TH, Nguyen K, Torralba M(2019) Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature 575(7783):505–511

24 Fischbach MA (2018) Microbiome: focus on causation and mechanism. Cell 174(4):785–790

25 Ford AC, Lacy BE, Talley NJ (2017) Irritable bowel syndrome. N Engl J Med 376(26):2566–2578

26 Franks PW, McCarthy MI (2016) Exposing the exposures responsible for type 2 diabetes and obesity. Science 354(6308):69–73

27 Galea S, Saitz R (2017) Funding, institutional conflicts of interest, and schools of public health: realities and solutions. JAMA 317 (17):1735–1736

28 Garrett WS (2015) Cancer and the microbiota. Science 348 (6230):80–86

29 Gehrig JL, Venkatesh S, Chang H-W, Hibberd MC, Kung VL, Cheng J,Chen RY, Subramanian S, Cowardin CA, Meier MF (2019) Effects of microbiota-directed foods in gnotobiotic animals and undernourished children. Science 365(6449):eaau4732

30 Gentile CL, Weir TL (2018) The gut microbiota at the intersection of diet and human health. Science 362(6416):776–780

31 Gilbert JA, Quinn RA, Debelius J,Xu ZZ, Morton J, Garg N, Jansson JK, Dorrestein PC, Knight R (2016) Microbiome-wide association studies link dynamic microbial consortia to disease. Nature 535 (7610):94–103

32 Gilbert JA, Blaser MJ, Caporaso JG, Jansson JK, Lynch SV, Knight R (2018) Current understanding of the human microbiome. Nat Med 24(4):392–400

33 Goldszmid RS, Trinchieri G (2012) The price of immunity. Nat Immunol 13(10):932–938

34 Green JM, Barratt MJ, Kinch M, Gordon JI (2017) Food and microbiota in the FDA regulatory framework. Science 357 (6346):39–40

35 Greenhalgh S (2019) Making China safe for coke: how Coca-Cola shaped obesity science and policy in China. BMJ 364:k5050

36 Gribble FM, Reimann F (2019) Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocrinol 15(4):226–237

37 Guarino A, Canani RB (2016) Probiotics in childhood diseases: from basic science to guidelines in 20 years of research and development. J Pediatr Gastroenterol Nutr 63(Suppl 1):S1–S2

38 Hall AB, Tolonen AC, Xavier RJ (2017) Human genetic variation and the gut microbiome in disease. Nat Rev Genet 18(11):690–699

39 Hanage WP (2014) Microbiology: microbiome science needs a healthy dose of scepticism. Nature 512(7514):247–248

40 Hoffmann D, Palumbo F, Ravel J, Roghmann M-C, Rowthorn V, von Rosenvinge E (2017) Improving regulation of microbiota transplants . Science 358(6369):1390–1391

41 Hughes HK, Landa MM, Sharfstein JM (2017) Marketing claims for infant formula: the need for evidence. JAMA Pediatr 171(2):105–106

42 Inamo J (2019) Non-causal association of gut microbiome on the risk of rheumatoid arthritis: a Mendelian randomisation study. Ann Rheum Dis.https://doi.org/10.1136/annrheumdis-2019-216565

43 Isabella VM, Ha BN, Castillo MJ, Lubkowicz DJ, Rowe SE, Millet YA, Anderson CL, Li N, Fisher AB, West KA (2018) Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat Biotechnol 36(9):857–864

44 Iweala OI, Nagler CR (2019) The microbiome and food allergy. Annu Rev Immunol 37:377–403

45 Jia J, Dou P, Gao M, Kong X, Li C, Liu Z, Huang T (2019) Assessment of causal direction between gut microbiota-dependent metabolites and cardiometabolic health: a bidirectional mendelian randomization analysis. Diabetes 68(9):1747–1755

46 Johnson AJ, Vangay P, Al-Ghalith GA,Hillmann BM, Ward TL, Shields-Cutler RR, Kim AD, Shmagel AK, Syed AN, Personalized Microbiome Class Students (2019) Daily sampling reveals personalized diet-microbiome associations in humans. Cell Host Microbe 25(6):789–802.e5

47 Keith SW, Redden DT, Katzmarzyk PT, Boggiano MM, Hanlon EC, Benca RM, Ruden D, Pietrobelli A, Barger JL, Fontaine KR (2006) Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes 2005 30(11):1585–1594

48 Kivipelto M, Mangialasche F, Ngandu T (2018) Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease. Nat Rev Neurol 14(11):653–666

49 Kleerebezem M, Binda S, Bron PA, Gross G, Hill C, van Hylckama Vlieg JE, Lebeer S, Satokari R, Ouwehand AC (2019) Understanding mode of action can drive the translational pipeline towards more reliable health benefits for probiotics. Curr Opin Biotechnol 56:55–60

50 Knight R, Vrbanac A, Taylor BC, Aksenov A, Callewaert C, Debelius J,Gonzalez A, Kosciolek T,McCall L-I, McDonald D(2018) Best practices for analysing microbiomes. Nat Rev Microbiol 16 (7):410–422

51 Komaroff AL (2017) The microbiome and risk for obesity and diabetes. JAMA 317(4):355–356

52 Lagier J-C, Dubourg G, Million M, Cadoret F, Bilen M, Fenollar F, Levasseur A, Rolain J-M, Fournier P-E,Raoult D (2018) Culturing the human microbiota and culturomics. Nat Rev Microbiol 16 (9):540–550

53 Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto J-M,Kennedy S (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500(7464):541–546

54 Levin ME, Botha M, Basera W,Facey-Thomas HE, Gaunt B, Gray CL, Kiragu W, Ramjith J, Watkins A, Genuneit J (2020) Environmental factors associated with allergy in urban and rural children from the South AFrican Food Allergy (SAFFA) cohort. J Allergy Clin Immunol 145(1):415–426

55 Lloyd-Price J, Abu-Ali G, Huttenhower C (2016) The healthy human microbiome. Genome Med 8(1):51

56 Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375(24):2369–2379

57 Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, Costa FRC, Tiniakou E, Greiling T,Ruff W (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359(6380):1156–1161

58 Mayer EA (2011) Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 12(8):453–466

59 Meisel M, Hinterleitner R, Pacis A, Chen L, Earley ZM, Mayassi T, Pierre JF, Ernest JD, Galipeau HJ, Thuille N (2018) Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557(7706):580–584

60 Miller V,Mente A, Dehghan M, Rangarajan S, Zhang X, Swaminathan S, Dagenais G,Gupta R, Mohan V, Lear S (2017) Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Lancet Lond Engl 390(10107):2037–2049

61 Mitselou N, Hallberg J, Stephansson O, Almqvist C, Melén E,Ludvigsson JF (2018) Cesarean delivery, preterm birth, and risk of food allergy: nationwide Swedish cohort study of more than 1 million children. J Allergy Clin Immunol 142(5):1510–1514.e2

62 Mozaffarian D (2017) Conflict of interest and the role of the food industry in nutrition research. JAMA 317(17):1755–1756

63 Nayfach S, Shi ZJ, Seshadri R, Pollard KS, Kyrpides NC (2019) New insights from uncultivated genomes of the global human gut microbiome. Nature 568(7753):505–510

64 Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S (2012) Host-gut microbiota metabolic interactions. Science 336(6086):1262–1267

65 NIH Human Microbiome Portfolio Analysis Team (2019) A review of 10 years of human microbiome research activities at the US National Institutes of Health, Fiscal Years 2007–2016. Microbiome 7(1):31

66 Nissen SE (2017) Conflicts of interest and professional medical associations: progress and remaining challenges. JAMA 317 (17):1737–1738

67 O’Doherty KC, Virani A, Wilcox ES (2016) The human microbiome and public health: social and ethical considerations. Am J Public Health 106(3):414–420

68 O’Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7(7):688–693

69 Pararajasingam A, Uwagwu J (2017) Lactobacillus: the not so friendly bacteria. BMJ Case Rep 2017:bcr-2016-218423

70 Pennisi E (2017) Survey of archaea in the body reveals other microbial guests. Science 358(6366):983

71 Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S (2019) Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology 157(3):647–659.e4

72 Poussin C, Sierro N, Boué S, Battey J, Scotti E, Belcastro V, Peitsch MC, Ivanov NV, Hoeng J (2018) Interrogating the microbiome: experimental and computational considerations in support of study reproducibility. Drug Discov Today 23(9):1644–1657

73 Proctor L (2019) Priorities for the next 10 years of human microbiome research. Nature 569(7758):623–625

74 Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55–60

75 Quince C, Walker AW, Simpson JT, Loman NJ, Segata N (2017) Shotgun metagenomics, from sampling to analysis. Nat Biotechnol 35(9):833–844

76 Rastelli M, Cani PD, Knauf C (2019) The gut microbiome influences host endocrine functions. Endocr Rev 40(5):1271–1284

77 Rehfeld JF (1998) The new biology of gastrointestinal hormones. Physiol Rev 78(4):1087–1108

78 Reynolds LA, Finlay BB (2017) Early life factors that affect allergy development. Nat Rev Immunol 17(8):518–528

79 Rhodes R (2016) Ethical issues in microbiome research and medicine. BMC Med 14(1):156

80 Richard ML, Sokol H (2019) The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases. Nat Rev Gastroenterol Hepatol 16(6):331–345

81 Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science . 341(6150):1241214

82 Rooks MG, Garrett WS (2016) Gut microbiota, metabolites and host immunity. Nat Rev Immunol 16(6):341–352

83 Rosshart SP, Herz J, Vassallo BG, Hunter A, Wall MK, Badger JH, McCulloch JA, Anastasakis DG, Sarshad AA, Leonardi I (2019) Laboratory mice born to wild mice have natural microbiota and model human immune responses. Science 365(6452): eaaw4361

84 Schiattarella GG, Sannino A, Toscano E, Giugliano G, Gargiulo G, Franzone A, Trimarco B, Esposito G, Perrino C (2017) Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis. Eur Heart J 38(39):2948–2956

85 Schloss PD (2018) Identifying and overcoming threats to reproducibility, replicability, robustness, and generalizability in microbiome research. mBio 9(3):e00525–18

86 Schmidt TSB, Raes J, Bork P (2018) The human gut microbiome: from association to modulation. Cell 172(6):1198–1215

87 Schroeder BO, Bäckhed F (2016) Signals from the gut microbiota to distant organs in physiology and disease. Nat Med 22(10):1079–1089

88 Scott AJ, Alexander JL, Merrifield CA, Cunningham D, Jobin C, Brown R, Alverdy J, O’Keefe SJ, Gaskins HR, Teare J (2019) International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis. Gut 68(9):1624–1632

89 Sekirov I,Russell SL, Antunes LCM, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90(3):859–904

90 Servick K (2016) Of mice and microbes. Science 353(6301):741–743

91 Shamarina D, Stoyantcheva I, Mason CE, Bibby K, Elhaik E (2017) Communicating the promise, risks, and ethics of large-scale, open space microbiome and metagenome research. Microbiome 5(1):132

92 Shanahan F, Hill C (2019) Language, numeracy and logic in microbiome science. Nat Rev Gastroenterol Hepatol 16(7):387–388

93 Sharon G, Sampson TR, Geschwind DH, Mazmanian SK (2016) The central nervous system and the gut microbiome. Cell 167(4):915–932

94 Shendure J, Balasubramanian S, Church GM, Gilbert W, Rogers J, Schloss JA, Waterston RH (2017) DNA sequencing at 40: past, present and future. Nature 550(7676):345–353

95 Shkoporov AN, Hill C (2019) Bacteriophages of the human gut: the “known unknown” of the microbiome. Cell Host Microbe 25 (2):195–209

96 Singh P, Mitsuhashi S, Ballou S, Rangan V, Sommers T, Cheng V,Iturrino-Moreda J, Friedlander D, Nee J, Lembo A (2018a) Demographic and dietary associations of chronic diarrhea in a representative sample of adults in the United States. Am J Gastroenterol 113(4):593–600

97 Singh V, Yeoh BS, Chassaing B, Xiao X, Saha P, Aguilera Olvera R, Lapek JD, Zhang L, Wang W-B, Hao S (2018b) Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer. Cell 175(3):679–694.e22

98 Skelly AN, Sato Y, Kearney S, Honda K (2019) Mining the microbiota for microbial and metabolite-based immunotherapies. Nat Rev Immunol 19(5):305–323

99 Sox HC (2017) Conflict of interest in practice guidelines panels. JAMA 317(17):1739–1740

100 Stead WW (2017) The complex and multifaceted aspects of conflicts of interest. JAMA 317(17):1765–1767

101 Suez J, Zmora N, Zilberman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, Zur M, Regev-Lehavi D, Ben-Zeev Brik R, Federici S (2018) Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell 174(6):1406–1423.e16

102 The Lancet null (2019) Dietary supplement regulation: FDA’s bitter pill. Lancet Lond Engl 393(10173):718

103 Thornton JP (2017) Conflict of interest and legal issues for investigators and authors. JAMA 317(17):1761–1762

104 Tilg H, Zmora N, Adolph TE, Elinav E (2020) The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol 20 (1):40–54

105 Tordesillas L, Berin MC, Sampson HA (2017) Immunology of food allergy. Immunity 47(1):32–50

106 Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122):1027–1031

107 Untangle food industry influences on health (2019) Nat Med 25 (11):1629

108 Uzbay T (2019) Germ-free animal experiments in the gut microbiota studies. Curr Opin Pharmacol 49:6–10

109 Vaughn BP, Rank KM, Khoruts A (2019) Fecal microbiota transplantation: current status in treatment of gi and liver disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 17(2):353–361

110 Verbeke F, Janssens Y, Wynendaele E, De Spiegeleer B (2017) Faecal microbiota transplantation: a regulatory hurdle? BMC Gastroenterol 17(1):128

111 Vitiello GA, Cohen DJ, Miller G (2019) Harnessing the microbiome for pancreatic cancer immunotherapy. Trends Cancer 5(11):670–676

112 Weiner HL, da Cunha AP, Quintana F, Wu H (2011) Oral tolerance. Immunol Rev 241(1):241–259

113 Wong SH, Yu J (2019) Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol 16(11):690–704

114 Yelin I, Flett KB, Merakou C, Mehrotra P, Stam J, Snesrud E, Hinkle M, Lesho E, McGann P, McAdam AJ (2019) Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients. Nat Med 25(11):1728–1732

115 Yoo BB, Mazmanian SK (2017) The enteric network: interactions between the immune and nervous systems of the gut. Immunity 46(6):910–926

116 Yu L-X, Schwabe RF (2017) The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol 14(9):527–539

117 Yuan J, Chen C,Cui J, Lu J, Yan C,Wei X, Zhao X,Li N, Li S, Xue G et al (2019) Fatty liver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab 30(6):1172

118 Zeevi D, Korem T, Zmora N, Israeli D, Rothschild D, Weinberger A, Ben-Yacov O, Lador D, Avnit-Sagi T, Lotan-Pompan M (2015) Personalized nutrition by prediction of glycemic responses. Cell 163(5):1079–1094

119 Zeilstra D, Younes JA, Brummer RJ, Kleerebezem M (2018) Perspective: fundamental limitations of the randomized controlled trial method in nutritional research: the example of probiotics. Adv Nutr Bethesda Md 9(5):561–571

120 Zhang X, Li L, Butcher J, Stintzi A, Figeys D (2019) Advancing functional and translational microbiome research using metaomics approaches. Microbiome 7(1):154

121 Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J et al (2018) Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359(6380):1151–1156

122 Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL (2019a) Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science 363(6427):eaat9931

123 Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL (2019b) Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570(7762):462–467

124 Zmora N, Zeevi D, Korem T, Segal E, Elinav E (2016) Taking it personally: personalized utilization of the human microbiome in health and disease. Cell Host Microbe 19(1):12–20

125 Zuger A (2017) What do patients think about physicians’ conflicts of interest?: watching transparency evolve. JAMA 317(17):1747–1748